Sunday 18 October 2026
Export CCCC’s income statement to Excel — free account
C4 Therapeutics, Inc.
CCCC Healthcare Biotechnology
C4 Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $35.9 million, up 1.02% from fiscal 2024. In the quarter to June 2026, revenue grew 2.75%, EPS grew 51.4% and free cash flow grew 86.8%, each against the same quarter a year earlier.
2.77
0.01
−0.36%
Follow CCCC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 3 | 4 | 2 |
+8 more TTM periods Free account |
| (48.14%) | (48.35%) | (44.44%) | (59.98%) | ||
| (30.92%) | (32.02%) | (29.63%) | (37.12%) | ||
ROIC |
0.00% | 0.00% | (894.58%) | 0.00% | |
Return on Tangible Assets |
(46.35%) | (46.63%) | (45.68%) | (67.64%) | |
Average Days of Receivables |
13.90 | 30.19 | 24.38 | 79.31 | |
Free Cash Flow per Share |
(0.65) | (0.76) | (1.20) | (1.31) | |
Free Cash Flow |
(85.39) | (96.02) | (99.30) | (95.06) | |
Capital Expenditures |
(0.52) | (0.67) | (0.60) | (0.58) | |
| Other line items | |||||
Cash ROIC |
(17.05%) | (20.43%) | (19.66%) | (27.45%) | |
Accounts Receivable Turnover |
20.07 | 6.39 | 13.06 | 3.57 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
285.53% | 291.94% | 289.98% | 371.23% | |
Selling, General and Administrative Expense of Revenue |
102.81% | 103.83% | 100.69% | 124.19% | |
Share Based Compensation of Revenue |
40.83% | 46.65% | 53.13% | 77.48% | |
Interest Coverage |
8.63 | 8.75 | 6.70 | — | |
Operating CF/Net income |
0.84 | 0.92 | 0.94 | 0.79 | |
Depreciation/Fixed assets |
(0.26) | (0.25) | (0.17) | (0.18) | |
Capex/Depreciation |
0.49 | 0.59 | 0.77 | 0.61 | |
Revenue per Share |
0.27 | 0.28 | 0.43 | 0.41 | |
Operating CF per Share |
(0.65) | (0.76) | (1.19) | (1.30) | |
Capex per Share |
0.00 | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.02 |
Columns are period end dates